254 related articles for article (PubMed ID: 12456313)
1. The role of matrix metalloproteinases in glioma invasion.
Nakada M; Okada Y; Yamashita J
Front Biosci; 2003 Jan; 8():e261-9. PubMed ID: 12456313
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their biological function in human gliomas.
Chintala SK; Tonn JC; Rao JS
Int J Dev Neurosci; 1999; 17(5-6):495-502. PubMed ID: 10571411
[TBL] [Abstract][Full Text] [Related]
3. Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.
Fillmore HL; VanMeter TE; Broaddus WC
J Neurooncol; 2001 Jun; 53(2):187-202. PubMed ID: 11716070
[TBL] [Abstract][Full Text] [Related]
4. The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.
VanMeter TE; Rooprai HK; Kibble MM; Fillmore HL; Broaddus WC; Pilkington GJ
J Neurooncol; 2001 Jun; 53(2):213-35. PubMed ID: 11716072
[TBL] [Abstract][Full Text] [Related]
5. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.
Uhm JH; Dooley NP; Villemure JG; Yong VW
Clin Exp Metastasis; 1996 Oct; 14(5):421-33. PubMed ID: 8871536
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases in tumour invasion and metastasis.
Curran S; Murray GI
J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
8. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades.
Wang M; Wang T; Liu S; Yoshida D; Teramoto A
Brain Tumor Pathol; 2003; 20(2):65-72. PubMed ID: 14756443
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12.
Sarkar S; Nuttall RK; Liu S; Edwards DR; Yong VW
Cancer Res; 2006 Dec; 66(24):11771-80. PubMed ID: 17178873
[TBL] [Abstract][Full Text] [Related]
10. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell-matrix interaction: pericellular matrix degradation and metastasis.
Okada Y
Verh Dtsch Ges Pathol; 2000; 84():33-42. PubMed ID: 11217446
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
13. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.
Wang M; Yoshida D; Liu S; Teramoto A
J Neurooncol; 2005 Mar; 72(1):1-9. PubMed ID: 15803368
[TBL] [Abstract][Full Text] [Related]
15. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
Zhao JX; Yang LP; Wang YF; Qin LP; Liu DQ; Bai CX; Nan X; Shi SS; Pei XJ
Eur J Neurol; 2007 May; 14(5):510-6. PubMed ID: 17437609
[TBL] [Abstract][Full Text] [Related]
16. [Role of extracellular matrix degradation enzyme for glioma invasion].
Nakada M
Nihon Rinsho; 2005 Sep; 63 Suppl 9():55-60. PubMed ID: 16201500
[No Abstract] [Full Text] [Related]
17. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
Kubiatowski T; Jang T; Lachyankar MB; Salmonsen R; Nabi RR; Quesenberry PJ; Litofsky NS; Ross AH; Recht LD
J Neurosurg; 2001 Sep; 95(3):480-8. PubMed ID: 11565871
[TBL] [Abstract][Full Text] [Related]
18. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
19. The other side of MMPs: protective roles in tumor progression.
Martin MD; Matrisian LM
Cancer Metastasis Rev; 2007 Dec; 26(3-4):717-24. PubMed ID: 17717634
[TBL] [Abstract][Full Text] [Related]
20. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]